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If you think of standardization as the best that you know today, but
which is to be improved tomorrow; you get somewhere
Henry Ford
Aortic stenosis (AS) is the most common valvular heart disease in
western countries. Because of the ageing population, AS is being
an increasing health problem with sizeable economic impact.1 AS
is a gradually progressive disease, characterized by a long asymp-
tomatic phase, lasting several decades, followed by a shorter symp-
tomatic phase associated with severe narrowing of the orifice of the
aortic valve. Once symptoms occur, the prognosis is poor and with-
out treatment; patients usually die within 2–3 years.2,3 Surgical
aortic valve replacement is considered the standard treatment for
symptomatic AS. Transcatheter aortic valve implantation (TAVI)
has recently emerged as an alternative therapy for patients with
severe AS who are not candidates for surgery or are at high risk
for complications due to surgery.4 TAVI is non-inferior to surgery
in terms of early and mid-term mortality and is likely to be superior
if the patient has vascular anatomy and vessels that are healthy
enough to be treated with the use of a transfemoral approach.4,5
However, despite its favourable haemodynamics, paravalvular aortic
regurgitation (PVAR) is common after TAVI.6 PVAR is an independ-
ent predictor of short- and long-term mortality, though the impact
of mild regurgitation remains controversial.4,5
The accurate assessment of PVAR severity is warranted but
remains challenging. Doppler echocardiography is the most used
imaging technique to assess AR severity.7 The origin and direction
of the jets should be evaluated.8 The optimal views for detection
of regurgitant jets include the parasternal long-axis, short-axis
(SAX), apical long-axis, and five-chamber views. Because PVAR
jets travel along the natural curvature of the prosthesis annular
interface (eccentric jets), imaging in multiple planes including off-axis
views is necessary. Colour Doppler evaluation should be performed
just below the valve stent for paravalvular jets and at the coaptation
point of the leaflets for central regurgitation. The entire circumfer-
ence of the valve ring must be assessed using the parasternal
short-axis view. Apical views should thus be carefully examined to
properly detect and quantitate potential posterior jets that maybe
missed in the parasternal views (shadowing effect of the stent).9
Generally, the same principles and methods used for quantifica-
tion of other prosthetic valves are used with determination of
flow convergence zone, measurement of the vena contracta, and
extent of regurgitation into the left ventricle and spectral Doppler
parameters such as the pressure half-time and diastolic flow reversal
into the descending aorta.10 However, there are very limited data on
the application and validation of these parameters (e.g. vena con-
tracta width, effective regurgitant orifice area, regurgitant volume)
in the context of TAVI. Recently, the Valve Academic Research
Consortium (VARC) has revisited the echocardiographic criteria
for defining PVAR severity after TAVI.8 The VARC-II adopted the
SAX criterion as ‘critical’ in assessing the number and severity of
paravalvular jets. With this approach, identification of the true
neck of the jet is mandatory.
Due to the complexity of certain PVARs and the limitation of the
echocardiography in certain situations (acoustic shadowing, eccen-
tric jets, multiple jets), the evaluation of the PVAR might need to be
completed with other imaging techniques [3D echocardiography,
cardiac magnetic resonance (CMR), computed tomography (CT),
invasive angiography].11,12 3D echocardiography, especially during
transoeophageal echocardiography, is ideal for imaging the entire
aortic prosthesis, the whole ring, and the extent of paravalvular
leak. Limited echocardiographic windows, tissue dropout, poor
temporal resolution, and the lack of validated data are the common-
est limitations of 3D echocardiography. ECG-gated CT with 3D
reconstruction is a promising tool in PVARs evaluation. CMR might
be a useful supplement to echocardiography and might be the
modality of choice when there is discordance in grading from differ-
ent echocardiographic windows. However, the lack of evidence, in-
consistency of definitions of PVAR severity, and its limited availability
represent the main limitations to the widespread use of CMR for
assessing AR after TAVI. After implantation, the angiographic
grading of PVAR is an easy-to-use method. PVAR can be classified
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according to the visually estimated density of opacification of the LV
into three degrees (mild, moderate, and severe) adapted to the
VARC-II 2 criteria.8 Its major challenge is the delimitation of the
3D anatomic and spatial characteristics of the leak. Hence, a consid-
erable overlap from one grade to another can be possible.
In recent studies, the angiographically assessed degree of PVAR
correlated with echocardiography in patients with TAVI.13 These
data are consistent with those elegantly reported by Abdelghani
et al.14 in a total of 165 patients treated with a self-expanding bio-
prosthesis who underwent contemporary angiographic and trans-
thoracic echocardiography (TTE). In this study, the authors sought
to investigate inter-technique (angiography and TTE) reproducibility
of the assessment of PVAR after TAVI. Consistency between angiog-
raphy and colour Doppler TTE, using the VARC-II criteria, in the
grading of post-TAVI PVAR was modest. These data underscore
the difficulty to visualize complex PVAR jets, which can run unpre-
dictable and variable courses (e.g. multiple jets; jets originating at the
non-coronary sinus, jets spreading out in all directions; jets running
in a circumferential direction into the inflow area of the stent
frame).15 To adequately image the origin of the PVAR jet in the
SAX, a colour Doppler scanning over the entire height of the stent
is necessary. However, as shown by Abdelghani et al., long-axis
(LAX) colour Doppler (combining parasternal and apical views)
was better correlated with angiography than SAX evaluation. More-
over, the combination of colour Doppler data (¼PVAR jet circum-
ferential extent (%) + LAX score) with pressure half-time improved
the predictive value of TTE, yielding good positive (85%) and nega-
tive (81%) predictive values for identifying greater than mild PVAR.
In practice, this methodology although unsatisfactory is easy to use
for initial evaluation and monitoring after the procedure. However,
the most appropriate time point to assess PVAR after TAVI remains
undefined. In their study, TTE was obtained at a maximum interval of
7 days after angiographic evaluation. The different haemodynamic
circumstances and the continuing expansion of the nitinol frame
of the CoreValve after implantation might have hampered the
accuracy of TTE assessment of AR. Therefore, generalization of
the results to other devices or when TTE is performed in the
cath lab should be done with caution.
In conclusion, the main current limitation for PVAR quantification
is the absence of a method of reference. Aortic root angiography
is the first screening method in the majority of laboratories
while echocardiography often serves to confirm and monitor
TAVI results. At present, integrating multiple TTE qualitative,
semi-quantitative, and quantitative findings should remain the
recommended approach for assessing PVAR. With regard to AR,
more specific, reproducible, and quantitative criteria need to be
developed with the goal of determining the ‘total’ AR, reflecting
the total volume load imposed on the left ventricle. Comparison
of regurgitant volumes obtained by new quantitative colour Dop-
pler approaches, 3D derived volumetric methods, and CMR might
refine the perceived meaning of AR and provide a standardized
imaging approach.
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